In 2012, she was diagnosed with polycystic kidney disease. "Polycystic kidney disease is where your kidneys are covered in cysts. The doctors have said that my kidneys look like t ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...

Theories suggest UTI and constipation are related, but one does not necessarily cause the other at this stage in research.

No randomized clinical trials have directly compared empagliflozin with dapagliflozin for type 2 diabetes, so investigators conducted a large comparative effectiveness study examining kidney outcomes.

The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

GPs struggle to integrate albuminuria screening for chronic kidney disease due to confusion over prescribing and interpreting ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side effects.

The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...